These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 8690621

  • 21. [Delayed action of oral antidiabetic treatments. Place of combination of insulin and hypoglycemic sulfamides].
    Leutenegger M, Nakib Y, Grulet H, Gross A, Boirie Y.
    Journ Annu Diabetol Hotel Dieu; 1993; ():97-114. PubMed ID: 8331877
    [No Abstract] [Full Text] [Related]

  • 22. Bedtime intermediate-acting insulin in the treatment of secondary failure to oral hypoglycemic agents.
    Chuang LM, Lu C, Su RJ, Wu HP, Tai TY, Lin BJ.
    J Formos Med Assoc; 1992 Feb; 91(2):185-9. PubMed ID: 1364216
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Insulin or insulin + oral hypoglycemic drugs in the treatment of type 2 diabetes difficult to compensate metabolically?].
    Carta Q, Trovati M, Dani F, Caselle MT, Vitali S, Cavalot F, Rocca G, Cantino G, Mularoni E, Libertucci D.
    Minerva Endocrinol; 1984 Feb; 9(2):241-5. PubMed ID: 6390138
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes.
    Kim G, Lee YH, Kang ES, Cha BS, Lee HC, Lee BW.
    Yonsei Med J; 2016 Nov; 57(6):1395-403. PubMed ID: 27593867
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [The treatment of type II diabetes].
    Curchod B, Chevaux F.
    Rev Med Suisse Romande; 1988 Jul; 108(7):559-64. PubMed ID: 3045938
    [No Abstract] [Full Text] [Related]

  • 30. [Inefficacy of oral antidiabetics: failure or natural history of diabetes?].
    Schönenweid C.
    Rev Med Suisse Romande; 1995 Sep; 115(9):671-3. PubMed ID: 7481353
    [No Abstract] [Full Text] [Related]

  • 31. Hyperglycemia in type II.
    DeLawter DE.
    Md Med J; 1988 Apr; 37(4):271. PubMed ID: 3285112
    [No Abstract] [Full Text] [Related]

  • 32. Type II diabetes: insulin versus oral agents.
    Chalmers TC.
    N Engl J Med; 1986 Nov 06; 315(19):1233-4. PubMed ID: 3531868
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Spectrum of erythrocyte membrane lipids in various types of hypoglycemic therapy].
    Kozlov GS, Buĭdina TA, Balabolkin MI.
    Sov Med; 1990 Nov 06; (6):10-3. PubMed ID: 2396109
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [When should stable maturity-onset diabetics be switched to insulin?].
    Selz B, Nyffenegger U, Bürgi H.
    Schweiz Med Wochenschr; 1980 Oct 18; 110(42):1534-7. PubMed ID: 7006072
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A diabetic day in the outback.
    Jackson S, Lyon J, Neilson G.
    Aust Fam Physician; 1994 Mar 18; 23(3):404-7. PubMed ID: 8048874
    [Abstract] [Full Text] [Related]

  • 40. [Choice of therapeutic modality for type II diabetes].
    Erkelens DW.
    Journ Annu Diabetol Hotel Dieu; 1988 Mar 18; ():63-71. PubMed ID: 3050235
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.